Related Experiment Video
Updated: Apr 30, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
The protective arms of the renin-angiontensin system in stroke
Claudia A McCarthy1, Lachlan J Facey, Robert E Widdop
1Department of Pharmacology, Monash University, Clayton, Victoria, 3800, Australia.
Abstract:
It is quite well established that activation of the so-called protective arms of the renin-angiotensin system (RAS), involving both AT2 and Mas receptors, provides a counter-regulatory role to AT1 receptor overactivity that may drive pathological changes in the cardiovascular system. In this brief review, we will focus on recent evidence that identifies at least three different pathways that may be effective in the setting of stroke and may be complementary with AT1 receptor blockade. Such mechanisms include AT2 receptor stimulation, Mas receptor stimulation and insulin-regulated aminopeptidase blockade. This report highlights recent data demonstrating striking neuroprotective effects in preclinical models of stroke targeting each of these pathways, which may pave the way for translational opportunities in this field.
Insights
Activating protective renin-angiotensin system (RAS) pathways, including AT2 and Mas receptors, offers neuroprotection against stroke. These strategies complement existing treatments by targeting stroke mechanisms.
Area of Science:
- Cardiovascular Research
- Neuroscience
- Pharmacology
Background:
- The renin-angiotensin system (RAS) plays a critical role in cardiovascular regulation.
- AT1 receptor overactivity is linked to cardiovascular pathologies.
- Protective RAS arms, including AT2 and Mas receptors, counterbalance AT1 effects.
Purpose of the Study:
- To review recent evidence on neuroprotective pathways in stroke.
- To explore complementary therapeutic strategies to AT1 receptor blockade.
- To highlight novel targets within the RAS for stroke treatment.
Main Methods:
- Review of preclinical stroke models.
- Analysis of studies targeting AT2 receptor stimulation.
- Evaluation of research on Mas receptor stimulation.
- Assessment of insulin-regulated aminopeptidase blockade efficacy.
Main Results:
- AT2 receptor stimulation demonstrates significant neuroprotective effects in stroke models.
- Mas receptor stimulation shows promise in mitigating stroke-induced damage.
- Insulin-regulated aminopeptidase blockade exhibits neuroprotective potential.
- These pathways offer complementary benefits to AT1 receptor blockade.
Conclusions:
- Targeting AT2, Mas receptors, and insulin-regulated aminopeptidase offers novel therapeutic avenues for stroke.
- These strategies present translational opportunities for stroke treatment.
- Activating protective RAS pathways can be a valuable addition to stroke management.
Related Concept Videos
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Hormonal Regulation
Hypertension II: Pathophysiology

